Observational, Prospective, Parallel Cohort Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea on a Background Therapy of Metformin With or Without a DPP-4 Inhibitor During Ramadan Fasting in Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Canagliflozin (Primary) ; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms CRATOS
- Sponsors Janssen-Cilag
- 14 Nov 2016 Status changed from active, no longer recruiting to completed.
- 13 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 12 May 2016 Status changed from not yet recruiting to recruiting.